UPDATE: Morgan Stanley Starts Arcutis Biotherapeutics Inc. (ARQT) at Overweight
Tweet Send to a Friend
(Updated - May 27, 2021 4:24 AM EDT)
Morgan Stanley analyst David Lebowitz initiates coverage on Arcutis Biotherapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst David Lebowitz initiates coverage on Arcutis Biotherapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
